Tamer Türk

Tamer Türk

Auto-generated profile, based on publicly available information

Tamer Türk

University of Health Sciences, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2008 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
AVA. Hakan Vural
A. Hakan Vural
SYSerhat Yalcinkaya
Serhat Yalcinkaya
TTTamer Türk
Tamer Türk
GYGündüz Yümün
Gündüz Yümün
NGNihal Gül
Nihal Gül
AÖAhmet Özyazicioğlu
Ahmet Özyazicioğlu

1 September 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
AAAhmet Kağan As
Ahmet Kağan As
MEMesut Engin
Mesut Engin
BABişar AMAÇ
Bişar AMAÇ
UAUfuk Aydın
Ufuk Aydın
CECüneyt Eriş
Cüneyt Eriş
TTTamer Türk
Tamer Türk
After cardiac surgery, acute kidney injury is observed at a rate of 5-30%, and the second most common cause of acute kidney injury in intensive care units is cardiac surgery. In this study, we aimed to investigate the effect of del Nido cardioplegia solution use on postoperative acute kidney injury development in patients who underwent coronary artery bypass grafting operation with cardiopulmonary bypass. Consecutive patients who underwent an elective coronary artery bypass grafting operation with cardiopulmonary bypass in our clinic between March 15, 2019, and March 15, 2020, were included in the study retrospectively. The patients were divided into two groups as those who received del Nido cardioplegia solution (Group 1) and blood cardioplegia (Group 2), and factors affecting the development of renal failure were examined. A total of 350 consecutive patients were included in the study. There were 156 patients in the del Nido cardioplegia group and 194 patients in the blood cardioplegia group. Among the patient group, 74 (21.1%) patients developed acute kidney injury. The total acute kidney injury development rate was significantly higher in Group 2 (p=0.018). In multivariate logistic regression analysis, advanced age (OR 1.128; 95%CI 1.044-1.217; p=0.042), increased blood product use (OR 1.318; 95%CI 1.154-1.998; p=0.019), preoperative creatinine elevation (OR 2.434; 95%CI 1.655-4.639; p=0.005), and increased cardioplegia volume (OR 1.254; 95%CI 1.109-2.980; p=0.009) were independent predictors of acute kidney injury. With this study, we showed that the use of del Nido cardioplegia solution can reduce the incidence of acute kidney injury.

3 January 2021 in The European Research Journal
Verified
Journal Article
Open access
PDF file
AAAhmet Kağan As
Ahmet Kağan As
MEMesut Engin
Mesut Engin
TTTamer Turk
Tamer Turk
Objectives: This study aimed to investigate the early results of the patients presented with acute coronary syndrome (ACS) who underwent coronary artery bypass grafting (CABG) after percutaneous coronary intervention (PCI) to the culprit lesion.Methods: Patients who underwent CABG between January 2011 and January 2014 were enrolled and divided into two groups. Group 1 (102 patients) was consist of the patients who were hospitalized with ACS and underwent CABG after a previous PCI. Group 2 (107 patients) was consisting of the patients who underwent elective CABG operation after elective coronary angiography.Results: There was no statistically significant difference between the groups in terms of demographic features and preoperative risk factors. Preoperative use of angiotensin-converting enzyme inhibitor and levosimendan were significantly higher in group 1 compared to group 2. (95 (93.1%) vs. 89 (83.1%), p = 0.027). The operative variables were similar between two groups whereas the postoperative blood drainage amounts were significantly higher in group 1 than group 2 (546.3 ± 172 cc vs. 424.2 ± 185 cc, respectively, p < 0.001). The blood product usage was significantly higher in group 1 than in group 2 (3.3 ± 1.8 units vs.1.7 ± 0.9 units, respectively, p < 0.001).Conclusions: Early CABG operation after ACS is a safely applicable process with acceptable mortality and complication rates.

27 May 2022 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
UAUfuk Aydın
Ufuk Aydın
MEMesut Engin
Mesut Engin
NKNurcan KAT
Nurcan KAT
AAAhmet Kağan AS
Ahmet Kağan AS
ADAbdurrahman Demirel
Abdurrahman Demirel
TTTamer Türk
Tamer Türk

11 August 2021 in The Cardiothoracic Surgeon
Verified
Journal Article
Open access
PDF file
TTTamer Türk
Tamer Türk
UAUfuk Aydın
Ufuk Aydın
MEMesut Engin
Mesut Engin
YAYusuf Ata
Yusuf Ata

1 August 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
TTTamer Turk
Tamer Turk
MSMuhammed Savran
Muhammed Savran
MEMesut Engin
Mesut Engin